Short seller convicted of fraud after boasting ‘it’s like taking candy from a baby’ The investor took to social media after the verdict, writing, ‘This is not over’ The Independent UK · Jun 2
Short seller Andrew Left convicted of securities fraud A federal grand jury in California has convicted short seller Andrew Left of securities fraud AAP · Jun 2
Who Is Andrew Left? Wall Street's Prominent Short Seller Found Guilty Of Fraud, May Face Jail Time Andrew Left, founder of Citron Research, was found guilty of securities fraud, accused of manipulating stocks and defrauding investors, potentially facing 45 years in prison. International Business Times UK · Jun 2
Long Bitcoin, Short MicroStrategy: Citron Research 'Proud Of The Timing' One Year Later Short seller Citron Research, led by Andrew Left, made a prediction one year ago. The firm bet on Bitcoin (CRYPTO: BTC), but against the Bitcoin treasury company Strategy Inc (NASDAQ:MSTR). Here are the results of the trade. Benzinga · Nov 21, 2025
This Little-Known Nuclear Energy Stock Is ‘the Most Important Company in America’ Amentum Holdings has quickly become a key nuclear and defense contractor with a discounted valuation, record backlog, and growing analyst attention, making it a quietly strategic play on U.S. energy security and military modernization. Barchart · Nov 21, 2025
Nvidia Hits $5 Trillion: Is This The Next Dot-Com Bubble Or AI Gold Rush? The 56x Return Investor Speaks As chipmaker NVIDIA Corp. (NASDAQ:NVDA) surges past $5 trillion in market capitalization, several prominent analysts have reacted to the stock’s unrelenting rally, amid growing concerns regarding its sustainability and speculations of an AI bubble. Benzinga · Oct 30, 2025
Short Seller Andrew Left Recalls Bet On Nebius As It Soars Over 130% In 2025: 'Just A Pat On The Back' From When NBIS Was At $20 Per Share Famed short-seller Andrew Left of Citron Research is taking a victory lap on a bullish call, celebrating his firm’s early bet on AI infrastructure company Nebius Group NV (NASDAQ:NBIS). Benzinga · Sep 9, 2025
Opendoor Attacked By Short Seller—Stock Pops Anyway Citron Research, led by famed short-seller Andrew Left, targeted Opendoor Technologies, Inc. (NASDAQ:OPEN) in a social media post on Friday. Opendoor investors shrugged off the attack, and the stock climbed. Benzinga · Sep 5, 2025
Jim Cramer Sees Palantir Riding MongoDB's Momentum: Sets Bold 24% Upside Target — Says 'Bears Didn't See Mongo Coming!' Television host Jim Cramer is once again reiterating his bullish stance on Palantir Technologies Inc. (NASDAQ:PLTR), tying the stock’s potential and his latest price target to the recent surge in MongoDB Inc. (NASDAQ:MDB). Benzinga · Aug 27, 2025
Palantir New All-Time Highs In 2025? Less Than 50% Say Yes In New Poll Palantir Technologies (NASDAQ:PLTR) stock has gained more than 100% year-to-date, hitting new all-time highs in August before a recent pullback. Benzinga · Aug 25, 2025
Palantir's AI Edge: PEG Ratio Outshines Salesforce—'Sleeper Valuation' Defying P/E Skeptics? In a landscape where high Price-to-Earnings (P/E) ratios often scare investors, a different metric defies skeptics that AI powerhouse, Palantir Technologies Inc. (NASDAQ:PLTR), which was battered last week for its high valuations following a Citron Research report, is not quite overpriced. Benzinga · Aug 25, 2025
How AI darling Palantir became the S&P 500’s best and worst stock of 2025, climbing 144% before shedding value in 6 straight sessions Over $73 billion has been wiped off high-flying Palantir’s market cap in recent days. Fortune · Aug 21, 2025
PLTR Stock Has Declined Over 15% In Past 5 Sessions, But This Tech Bull Says Palantir Remains 'Favorite' Despite a sharp sell-off that has seen Palantir Technologies Inc. (NYSE:PLTR) shares plummet nearly 15% in the last five sessions, Wedbush Securities analyst Dan Ives is urging investors to see the dip as a buying opportunity. Benzinga · Aug 21, 2025
Palantir Short Seller Andrew Left's Citron Now Compares It To Databricks: 'PLTR Is A $40 Stock, And Every Real AI Leader Keeps Reminding Us' Short-seller Andrew Left‘s Citron Research intensified its campaign against Palantir Technologies Inc. (NYSE:PLTR) on Wednesday, posting a direct comparison to private competitor Databricks that highlights Palantir’s slower growth on several key metrics. Benzinga · Aug 20, 2025
Benzinga · Aug 19, 2025 Short Seller Andrew Left Says 'OpenAI At $500 Billion Puts Palantir At $40' — And That's Generous Renowned short-seller Andrew Left's Citron Research has issued a bearish report on Palantir Technologies Inc. (NASDAQ:PLTR), arguing the stock is significantly overvalued and its price is "detached from fundamentals and analysis".
Benzinga · Aug 15, 2025 Marjorie Taylor Greene Keeps Buying UnitedHealth Stock Along With Fellow Investors Buffett And Burry Shares of UnitedHealth Group (NYSE:UNH) soared on Friday with news that several prominent investors had purchased shares of the health insurance company.
Benzinga · Aug 15, 2025 GameStop Short Seller Bets Against Palantir — Goes Long UnitedHealth Alongside Buffett, Burry UnitedHealth Group (NYSE:UNH) stock is soaring Friday morning with a handful of large investors revealing long positions in the health insurance company via quarterly 13F filings.
Benzinga · Aug 14, 2025 Short Seller Slams Jim Cramer Over Palantir, Accuses Him Of Hyping 'High-Multiple, Hype-Driven Narrative' After $200 Price Target Call Famed short-seller Andrew Left's Citron Research publicly challenged CNBC's Jim Cramer over his bullish stance on Palantir Technologies Inc. (NASDAQ:PLTR).
Benzinga · Aug 13, 2025 GameStop Short Seller Andrew Left Is Taking On Retail Investors Again, Now Says Palantir Stock Is 'Beyond Overvalued' Citron Research founder and famed short seller Andrew Left announced a new short pick on Wednesday during an appearance on Fox Business.
Benzinga · Aug 5, 2025 Andrew Left Doubles Down On Rocket Companies: 'This Isn't A Meme,' It's A 'Housing Juggernaut' In The Making (CORRECTED) Editor's Note: This article has been updated to correct the individual’s name in the headline.
Evening Standard · Apr 4, 2025 Prince Andrew 'unsurprised' by accuser Virginia Giuffre's car crash claims, friends of Duke say The campaigner, who accused the Duke of York of sexually abusing her when she was 17, revealed she had ‘days to live’ following the collision with a school bus in Australia
Evening Standard · Apr 1, 2025 What happened to Virginia Giuffre? Everything we know as Epstein accuser 'fights for life' after car crash The sex trafficking survivor shocked fans on Monday after revealing she was hit by a bus and has ‘days to live’
Barchart · Feb 27, 2025 Citron Research Just Identified This 1 Stock to Buy as a ‘Hidden’ AI Winner Former short seller Citron Research is growing bullish on Teladoc's growth potential.
Fortune · Jan 23, 2025 Are famous short-sellers going extinct? The exit of Hindenburg Research and Andrew Left shows the risky trade is shrinking Indicted short-seller Andrew Left tells Fortune a chilling effect is making “everyone think twice.”
Benzinga · Dec 4, 2024 Andrew Left's Citron Research Says Nvidia-Backed Nebius Is The Next 'AI Wall Street Darling' — Stock Moves Up 14% Shares of Nebius Group NV (NASDAQ:NBIS) jumped 13.90% on Tuesday after Citron Research highlighted the company’s potential to become the next artificial intelligence sensation on Wall Street, citing its deep ties with NVIDIA Corp. (NASDAQ: